Drug Pricing Transparency Congress
September 27, 2018 - Philadelphia MA US
State drug pricing regulations remain in the headlines as state legislatures continue to introduce and pass laws aimed at transparency and reporting obligations leaving a myriad of legal and compliance complexities. Are you prepared for the impact on your compliance practices? Over the past year, states including Oregon, California, Nevada, Maryland, New York, Massachusetts and Vermont – to name a few – have introduced and/or enacted different laws and enforcement initiatives mandating the disclosure of drug pricing increases, introducing restrictions limiting Medicaid drug spending, requiring disclosure of company metrics and expenses, and other related pricing ballot initiatives.